The Economic Impact of Rare Disease Designations on Pharyngeal Therapy Growth
Many forms of pharyngeal cancer, particularly those in the nasopharynx, are classified as rare diseases in Western markets, leading to specialized regulatory pathways for drug development. These designations provide incentives for companies to invest in therapies that might otherwise have a limited patient population. Use cases for these "orphan drugs" often focus on specific genetic mutations...
0 Comments 0 Shares 363 Views 0 Reviews